课题基金 / 基金详情

Targeting the interleukin-1 receptor for treating ischemic eye diseases

Targeting the interleukin-1 receptor for treating ischemic eye diseases
靶向白介素 1 受体治疗缺血性眼病
批准号:
335739
负责人:
Lubell William D
金额:
$27.36万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-10-01 至 2018-10-01

项目摘要

项目成果

Lubell William D的其他基金

相似基金

相关文献

中文摘要
翻译
缺血性视网膜病变是由血管阻塞引起的损害视网膜的疾病。视网膜是眼睛的一部分,它拥有感知光线的细胞,以及为这些细胞输送营养的血管。氧化应激和
英文摘要
Ischemic retinopathies are diseases caused by obstruction of blood vessels that damage the retina. The retina is the part of the eye that possesses cells which sense light, as well as blood vessels that bring nutrients to these cells. Oxidant stress and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
  • 批准号:
    478746
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.62万
  • 财政年份:
    2023
  • 负责人:
    Lubell William D
  • 依托单位:
Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation
  • 批准号:
    468104
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.75万
  • 财政年份:
    2022
  • 负责人:
    Lubell William D
  • 依托单位:
Safe and selective anti-parasite therapy targeting ribosome and glycosome function
  • 批准号:
    451337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.65万
  • 财政年份:
    2021
  • 负责人:
    Lubell William D
  • 依托单位:
Allosteric Modulation of the Urotensin Receptor with Small-Molecule Peptide Mimics
  • 批准号:
    407925
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2019
  • 负责人:
    Lubell William D
  • 依托单位:
海外基金